First Time Loading...

Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0001 USD Market Closed
Updated: May 16, 2024

Operating Margin
Rosetta Genomics Ltd

-219.6%
Current
-395%
Average
-8.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-219.6%
=
Operating Profit
-12.8m
/
Revenue
5.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IL
Rosetta Genomics Ltd
OTC:ROSGQ
29.6k USD
-220%
US
Abbvie Inc
NYSE:ABBV
290.3B USD
30%
US
Amgen Inc
NASDAQ:AMGN
168.9B USD
24%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.4B USD
39%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.7B USD
30%
AU
CSL Ltd
ASX:CSL
138.6B AUD
26%
US
Gilead Sciences Inc
NASDAQ:GILD
84.6B USD
32%
US
Moderna Inc
NASDAQ:MRNA
50.9B USD
-100%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-33%
US
Biogen Inc
NASDAQ:BIIB
33.5B USD
22%
KR
Celltrion Inc
KRX:068270
40T KRW
30%
Country IL
Market Cap 29.6k USD
Operating Margin
-220%
Country US
Market Cap 290.3B USD
Operating Margin
30%
Country US
Market Cap 168.9B USD
Operating Margin
24%
Country US
Market Cap 113.4B USD
Operating Margin
39%
Country US
Market Cap 106.7B USD
Operating Margin
30%
Country AU
Market Cap 138.6B AUD
Operating Margin
26%
Country US
Market Cap 84.6B USD
Operating Margin
32%
Country US
Market Cap 50.9B USD
Operating Margin
-100%
Country US
Market Cap 43.1B USD
Operating Margin
-33%
Country US
Market Cap 33.5B USD
Operating Margin
22%
Country KR
Market Cap 40T KRW
Operating Margin
30%

Profitability Report

View the profitability report to see the full profitability analysis for Rosetta Genomics Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-219.6%
=
Operating Profit
-12.8m
/
Revenue
5.8m
What is the Operating Margin of Rosetta Genomics Ltd?

Based on Rosetta Genomics Ltd's most recent financial statements, the company has Operating Margin of -219.6%.